Compound Detail
CHEMBL5218654
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5218654 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | AEZYZYRYMVEDJV-AWEZNQCLSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
471.3
MW (Da)
1.92
ALogP
6
HBA
2
HBD
123.2
PSA (Ų)
0.55
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 7.17
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Complement factor D CHEMBL2176771 | IC50 | 7.17 | 7.17 | 67.0 | 1 |
| Erythrocyte CHEMBL4296518 | IC50 | 5.92 | 5.92 | 1200.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Complement factor D | IC50 | = | 67.0 | nM | 7.17 | Inhibition of human complement factor D using Z-L-Lys-SBzl hydrochloride as subs... | 36272185 |
| Erythrocyte | IC50 | = | 1200.0 | nM | 5.92 | Hemolytic activity against rabbit erythrocytes incubated for 30 mins in presence... | 36272185 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 36272185 | 10.1016/j.bmc.2022.117034 | Complement factor D | 1 |
| 36272185 | 10.1016/j.bmc.2022.117034 | Erythrocyte | 1 |
Data from ChEMBL 36 via Core Engine